Ironwood Pharmaceuticals | IRWD - Market Capitalization

Stock Price
3.40
Daily Change
-0.39 -10.29%
Monthly
-34.36%
Yearly
98.83%
Q1 Forecast
3.84

Ironwood Pharmaceuticals reported $593.2M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.09B 492M Feb/2026
Agios Pharmaceuticals USD 1.6B 16M Feb/2026
Akebia Therapeutics USD 322M 180M Jun/2025
Almirall EUR 2.75B 8.36M Feb/2026
Alnylam Pharmaceuticals USD 39.74B 12.8B Feb/2026
Amarin USD 341M 4M Sep/2025
Ardelyx USD 1.33B 390M Sep/2025
Astellas Pharma JPY 4.33T 546.23B Feb/2026
AstraZeneca USD 222.33B 65.82B Feb/2026
Charles River Laboratories USD 8.08B 1.94B Feb/2026
Coherus Biosciences USD 278M 184M Jun/2025
Emergent BioSolutions USD 125M 51M Dec/2023
Esperion Therapeutics USD 340M 235M Dec/2023
Exact Sciences USD 10.36B 334M Sep/2025
Halozyme Therapeutics USD 10.23B 2.31B Feb/2026
Incyte USD 22.7B 3.31B Feb/2026
Ironwood Pharmaceuticals USD 213M 97M Sep/2025
Lexicon Pharmaceuticals USD 267M 294M Sep/2023
MacroGenics USD 114M 8M Feb/2026
Moderna USD 16.5B 6.41B Feb/2026
Myriad Genetics USD 494M 316M Jun/2025
Pacira USD 1.16B 51M Sep/2025
PTC Therapeutics USD 5.36B 744M Feb/2026
Sarepta Therapeutics USD 1.77B 249M Feb/2026
Takeda JPY 7.64T 774.9B Dec/2025
Ultragenyx Pharmaceutical USD 1.94B 284M Feb/2026
Vanda Pharmaceuticals USD 243M 136M Dec/2023